(Q35558627)

8 August 2017

1 reference

title

Current diagnosis of histoplasmosis (English)

1 reference

8 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

21 March 2024

author name string

L. Joseph Wheat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14557032

21 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14557032

21 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0966842X03002397?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

https://api.elsevier.com/content/article/PII:S0966842X03002397?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

21 March 2024

published in

Trends in Microbiology

1 reference

8 August 2017

volume

11

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

488-494

1 reference

Clinical and Laboratory Features of Disseminated Histoplasmosis During Two Large Urban Outbreaks

8 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

21 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

21 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Cavitary histoplasmosis occurring during two large urban outbreaks. Analysis of clinical, epidemiologic, roentgenographic, and laboratory features.

21 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak

21 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature

21 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

An Epidemic of Histoplasmosis on the Isthmus of Panama

21 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Serodiagnosis of histoplasmosis

21 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Immunoglobulin M and G histoplasmal antibody response in histoplasmosis

21 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory

21 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens

21 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.

21 March 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole

21 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis

21 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels

21 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid

21 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Clearance of Histoplasma capsulatum variety capsulatum antigen is useful for monitoring treatment of experimental histoplasmosis

21 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Correlation of Histoplasma capsulatum polysaccharide antigen with the severity of infection in murine histoplasmosis

21 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

21 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice

21 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.

21 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome

21 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

21 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses

21 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue

21 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Rapid PCR-based diagnosis of disseminated histoplasmosis in an AIDS patient.

21 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Identification of Histoplasma capsulatum from culture extracts by real-time PCR.

21 March 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Significance of Histoplasma antigen in the cerebrospinal fluid of patients with meningitis

21 March 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Cerebrospinal fluid Histoplasma antibodies in central nervous system histoplasmosis.

21 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Histoplasma capsulatum infections of the central nervous system. A clinical review

21 March 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Diagnosis and monitoring of murine histoplasmosis by a nested PCR assay

21 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Hepatic granulomas in children. A clinicopathologic analysis of 23 cases including polymerase chain reaction for histoplasma

21 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Direct detection of Histoplasma capsulatum in soil suspensions by two-stage PCR

21 March 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Rapid diagnosis of Histoplasma capsulatum endocarditis using the AccuProbe on an excised valve

21 March 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Some factors in the epidemiology of histoplasmin sensitivity in Williamson County, Tennessee

21 March 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Effects of a single histoplasmin skin test on the serological diagnosis of histoplasmosis

21 March 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Cellular immune response in HIV-infected patients with histoplasmosis

21 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Pulmonary calcifications and histoplasmosis

21 March 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

The course and prognosis of histoplasmosis

21 March 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

21 March 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.TIM.2003.08.007

21 March 2024

Identifiers

1 reference

8 August 2017

1 reference